Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
RESEARCH TOOLSreports
Earnings Data
Report Date
Jul 24, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
1.52Last Year’s EPS
1.52Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Date:Apr 24, 2025
|% Change Since: -4.34%
|Next Earnings Date:Jul 24, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. While there were several areas of growth, particularly in the GLP-1 market and progress with AnnexOne, there were also notable challenges. These include reduced growth expectations for HPP components, a decline in FluroTech product sales, and challenges with contract manufacturing margins. The announcement of CFO Bernard Birkett's departure adds to the uncertainty. Overall, the highlights and lowlights are balanced.Company Guidance
During the West Pharmaceutical Services first quarter 2025 earnings call, the company provided guidance for the full fiscal year 2025. They increased their full-year revenue guidance to a range of $2.945 billion to $2.975 billion, up from the previous range of $2.875 billion to $2.905 billion, partly due to foreign currency exchange impacts. Organic sales growth is expected to be approximately 2% to 3%. The adjusted diluted EPS guidance was also raised to $6.15 to $6.35, compared to the previous range of $6.00 to $6.20. The guidance reflects a positive momentum, driven by strong performance in their GLP-1 elastomer business, which grew to 7% of total revenues, and anticipated high single-digit growth in Biologics HVP components in the second half of the year. However, the company noted a tariff headwind of $20 million to $25 million for the remaining three quarters, with mitigations being actively pursued.Revenue and EPS Beat Expectations
First quarter revenues and adjusted EPS exceeded expectations, largely driven by the GLP-1 market and reduced impact from industry-wide destocking.
Growth in Proprietary Products and Biologics
Proprietary products business grew by 0.6% (2.4% on an organic basis), with HVP components experiencing a CAGR of 13% over the past five years. Biologics market unit delivered mid-single digit organic net sales growth.
AnnexOne Progress
AnnexOne revenues were stronger than expected, contributing 200 basis points of total revenues, with 340 projects in various stages, up from 280 in the last earnings call.
GLP-1 Auto Injector Business Growth
Revenue growth in the GLP-1 auto injector business offset CGM contract exits, delivering low single digit growth for the contract manufacturing segment.
Improved Operating Margins
Gross profit margin increased by 10 basis points to 33.2%, and adjusted operating profit margin increased by 20 basis points to 17.9% year-over-year.
WST Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
WST Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 24, 2025 | $217.96 | $210.38 | -3.48% |
Feb 13, 2025 | $321.96 | $198.91 | -38.22% |
Oct 24, 2024 | $285.79 | $329.90 | +15.43% |
Jul 25, 2024 | $322.82 | $276.35 | -14.40% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does West Pharmaceutical Services, Inc. (WST) report earnings?
West Pharmaceutical Services, Inc. (WST) is schdueled to report earning on Jul 24, 2025, TBA Not Confirmed.
What is West Pharmaceutical Services, Inc. (WST) earnings time?
West Pharmaceutical Services, Inc. (WST) earnings time is at Jul 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is WST EPS forecast?
WST EPS forecast for the fiscal quarter 2025 (Q2) is 1.52.
